Veterinary Pain Management Drugs Market to hit US$ 3.00 Billion by 2031 | Top Companies - Zoetis, Elanco, Boehringer Ingelheim | Exclusive report by DataM Intelligence

Leander, Texas and Tokyo, Japan - Jan.07.2026
As per DataM intelligence research report" The Global Veterinary Pain Management Drugs Market reached US$ 2.06 billion in 2023 and is expected to reach US$ 3.00 billion by 2031, growing at a CAGR of 4.8% during the forecast period 2024-2031." Rising pet ownership and advanced animal healthcare are driving veterinary pain management solutions.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/veterinary-pain-management-market?prasad

United States: Recent Industry Developments

✅ In November 2025, Zoetis launched "Librela" (bedinvetmab) for canine osteoarthritis in the U.S. The monthly monoclonal antibody injection targets nerve growth factor (NGF) to alleviate pain It revolutionizes the management of chronic pain in American dogs

✅ In October 2025, Elanco received FDA approval for a new long-acting local anesthetic for surgery The drug provides 72 hours of post-op pain relief with a single application It improves recovery comfort for pets undergoing spay/neuter procedures

✅ In September 2025, Assisi Animal Health introduced a wearable PEMF device for cat pain The "Calmer Canine" technology uses pulsed electromagnetic fields to reduce inflammation It offers a non-drug option for managing feline arthritis and anxiety

✅ In August 2025, A U.S. veterinary compounding pharmacy released a transdermal gabapentin gel The gel allows owners to administer pain meds to cats without pill battles It improves compliance and quality of life for pets and owners

Japan: Recent Industry Developments

✅ In December 2025, Zenoaq (Nippon Zenyaku Kogyo) launched a new oral NSAID for dogs The tablet is flavored to improve palatability and acceptance It provides a standard-of-care option for acute pain in Japanese veterinary clinics

✅ In November 2025, DS Pharma Animal Health introduced a laser therapy system for rehab clinics The Class IV laser reduces pain and speeds up healing in musculoskeletal injuries It supports the growing field of veterinary rehabilitation in Japan

✅ In October 2025, A Japanese pet food company released a functional treat with green-lipped mussel The treat supports joint health and reduces inflammation in aging dogs It caters to the preventative care mindset of Japanese pet owners

✅ In September 2025, The Japanese Society of Veterinary Anesthesia and Analgesia updated pain scoring guidelines The new tools help vets and nurses accurately assess pain levels in cats and dogs It raises the standard of compassionate care in Japanese animal hospitals

veterinary pain management Market: Drivers
The veterinary pain management market is growing due to rising pet ownership and increased focus on animal welfare. Advances in veterinary medicine improve diagnosis and treatment of pain conditions. Growing awareness among pet owners drives demand for effective therapies. Expansion of veterinary clinics and specialty hospitals supports adoption. Development of safer analgesics enhances treatment outcomes. Regulatory approvals strengthen product availability. Livestock healthcare improvements further boost market growth.

Market growth is reinforced by innovations in long-acting and multimodal pain therapies. Increased spending on companion animal healthcare supports adoption. Emerging markets show rising demand due to improving veterinary infrastructure. Collaboration between pharmaceutical companies and veterinarians accelerates innovation. Focus on post-surgical and chronic pain management drives growth. Veterinary pain management is becoming integral to modern animal care.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/veterinary-pain-management-market?prasad

veterinary pain management Market: Major Players
Zoetis, Elanco, Boehringer Ingelheim, Dechra Pharmaceuticals, Merck Animal Health, and Ceva Santé Animale.

Segment Covered in the veterinary pain management Market:
By Drug Type
The market is segmented into NSAIDs 45%, opioids 20%, local anesthetics 15%, alpha-2 agonists 10%, and disease-modified osteoarthritis drugs (DMOADs) 10%, with NSAIDs dominating due to their widespread use, effectiveness, and availability for both companion and livestock animals. Opioids are used in severe and postoperative pain management. Local anesthetics and alpha-2 agonists are widely applied in surgical and diagnostic procedures. DMOADs are growing with increasing focus on long-term joint health and osteoarthritis management in animals.

By Route of Administration
Routes of administration include oral 50%, parenteral 35%, and topical 15%, with oral formulations dominating due to ease of administration and high compliance, particularly in companion animals. Parenteral drugs are widely used in surgical and acute care settings. Topical formulations are gaining traction for localized pain relief and dermatological conditions.

By Animal
Animal segments include companion animals 65% and livestock 35%, with companion animals dominating due to rising pet ownership, increased spending on animal healthcare, and growing awareness of pain management. Livestock pain management is expanding with improved veterinary care standards and regulatory focus on animal welfare.

By Application
Applications include postoperative pain 35%, joint pain 30%, cancer 15%, and others 20%, with postoperative and joint pain dominating due to high volumes of surgical procedures and prevalence of osteoarthritis in aging animals. Cancer pain management is growing with improved diagnosis and treatment availability.

By Distribution Channel
Distribution channels include veterinary hospitals & clinics 55%, retail pharmacies 25%, and online pharmacies 20%, with veterinary hospitals and clinics dominating due to prescription-based treatments and professional supervision. Retail pharmacies are expanding access to common pain medications. Online pharmacies are growing rapidly with digital adoption and home delivery convenience.

Regional Analysis
North America - 35% Share
North America leads with 35% share driven by advanced veterinary healthcare infrastructure, high pet adoption rates, and strong demand for companion animal pain management drugs. NSAIDs and oral formulations dominate. Veterinary hospitals and clinics are the primary distribution channels.

Europe - 25% Share
Europe holds 25% share with widespread adoption in countries such as Germany, the UK, and France. Companion animals dominate, with NSAIDs and DMOADs widely used. Strong animal welfare regulations and veterinary services support market growth.

Asia Pacific - 20% Share
Asia Pacific accounts for 20% share with increasing pet ownership and livestock management in China, India, and Japan. Oral and parenteral drugs dominate. Companion animal care is growing rapidly, driving market expansion.

Latin America - 10% Share
Latin America holds 10% share with adoption mainly in Brazil and Mexico. NSAIDs and oral formulations dominate. Improving veterinary services and livestock healthcare drive market development.

Middle East & Africa - 10% Share
Middle East & Africa records 10% share with growing veterinary healthcare adoption in UAE, Saudi Arabia, and South Africa. Companion animals dominate demand. Increasing awareness of animal welfare and veterinary infrastructure investments support market growth.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=veterinary-pain-management-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.